Please assess the completion status of the following clinical trial:

Trial Title: Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Participants will be 18 to 70 years of age~* Women may participate in the study, with the understanding that within the clinical population of fibromyalgia the there is a 7:1 ratio of female to male.~* Diagnosis of Fibromyalgia by 1990 ACR criteria (11/18 tender points)~* History of cervical or lumbar pain with fibromyalgia (this is expected in all patients since axial pain is required for diagnosis)~* Current stable treatment regimen for the last 4 weeks and projected stable treatment regimen for the next 2 months.~* English speaking~Exclusion Criteria:~* Current or history of cardiovascular, pulmonary, neurological, endocrine, or renal disease that would preclude the involvement in the study.~* TENS use in the last 5 years~* Pacemaker~* Uncontrolled blood pressure or diabetes~* Neuropathic pain condition~* Systemic autoimmune disorder (Lupus, PMR, RA, Psoriasis, Psoriatic arthritis)~* Spinal fusion - cervical or lumbar~* Metal implants in cervical or lumbar region~* Severe skin allergy to adhesive~* Allergy to nickel~* Pain level less than 4~* Pregnancy~* Epilepsy~* Change in or new drug or treatment program within the last month or in the next 2months, i.e. must have a stable treatment plan~* Unstable medical or psychiatric condition which in the opinion of the investigator could compromise the subject's welfare or confound the study results

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- ActiveTENS (Type: ACTIVE_COMPARATOR): Active TENS for 4 weeks of the study and will add an additional 4 weeks of active TENS for the last 4 weeks of the study.
- Placebo TENS (Type: PLACEBO_COMPARATOR): This group will receive placebo TENS for the first 4 weeks of the study and then active TENS for the last four weeks of the study.
- No TENS (Standard Care) (Type: NO_INTERVENTION): Participants will not receive TENS intervention during the first 4 weeks of the trial but will complete all testing procedures as the other two arms. This group will receive active TENS during the last 4 weeks of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).